Free E-newsletter Subscribe to Housecall. Our general interest e-newsletter keeps you up to date on a wide variety of health topics. Sign up now
The Rhogam shot can be administered into either a vein or a muscle. Most commonly, the shot is given in the buttocks or arm. All women with Rh negative blood are advised to receive the Rhogam injection during the 28th week of pregnancy and again after giving birth.
The most common side effects of RhoGAM and MICRhoGAM are swelling, hardening, redness, and mild pain at the site of the injection. A small number of patients have noted a slight fever. Your healthcare provider should provide you with a completed Patient Identification Card for you to retain and present to other healthcare providers.
Pain or tenderness at injection site; It is important to inform your health care provider of all drugs you are taking. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors, as well as over-the-counter products. Other drugs may interact with RhoGAM and cause additional side effects.
Rh o (D) immune globulin (RhIG) is a medication used to prevent RhD isoimmunization in mothers who are RhD negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when RhD negative people are given RhD positive blood. It is given by injection into muscle or a vein.
Find patient medical information for Rhogam Intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
We had a patient that needed a rhogam injection and my preceptor gave her a dorsogluteal IM. In school we were taught to do ventrogluteal IMs because of potential nerve damage and increased pain. I know dorsogluteal is still commonly done and I have a few questions for you all, What site do you usually use for Rhogam?
RhoGAM Administration. Each single dose prefilled syringe of RhoGAM contains 300 μg (1500 IU) of Rh o (D) Immune Globulin (Human). This is the dose for the indications associated with pregnancy at or beyond 13 weeks unless there is clinical or laboratory evidence of a fetal-maternal hemorrhage (FMH) in excess of 15 mL of Rh-positive red blood cells.
RhoGAM ® and MICRhoGAM ® are intended for maternal administration. Do not inject the newborn infant. Local adverse reactions may include redness, swelling, and mild pain at the site of injection and a small number of patients have noted a slight elevation in temperature. Patients should be observed for at least 20 minutes after administration.
Do not use the gluteal muscle as a routine injection site due to the risk of sciatic nerve injury. If the gluteal region is used, the injection should be made only into the upper, outer quadrant. RhoGAM, MICRhoGAM, or Rhophylac: Observe patients for at least 20 minutes after administration.